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Abstract
Candida dubliniensis is an important human fungal pathogen that causes oral infections in patients with AIDS and
diabetes mellitus. However, C. Dubliniensis has been frequently reported in bloodstream infections in clinical
settings. Like its phylogenetically related virulent species C. albicans, C. Dubliniensis is able to grow and switch
between yeast form and filamentous form (hyphae) and develops biofilms on both abiotic and biotic surfaces.
Biofilms are recalcitrant to antifungal therapies and C. Dubliniensis readily turns drug resistant upon repeated
exposure. More than 80% of infections are associated with biofilms. Suppression of fungal biofilms may therefore
represent a viable antifungal strategy with clinical relevance. Here, we report that C. dubliniensis biofilms were
inhibited by purpurin, a natural anthraquinone pigment isolated from madder root. Purpurin inhibited C. dubliniensis
biofilm formation in a concentration-dependent manner; while mature biofilms were less susceptible to purpurin.
Scanning electron microscopy (SEM) analysis revealed scanty structure consisting of yeast cells in purpurin-treated
C. dubliniensis biofilms. We sought to delineate the mechanisms of the anti-biofilm activity of purpurin on C.
Dubliniensis. Intracellular ROS levels were significantly elevated in fungal biofilms and depolarization of MMP was
evident upon purpurin treatment in a concentration-dependent manner. DNA degradation was evident. However, no
activated metacaspase could be detected. Together, purpurin triggered metacaspase-independent apoptosis in C.
dubliniensis biofilms.
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Introduction
Invasive fungal infections have long been one of the most
important medical problems in humans [1-3]. Candida fungi,
among others, are prevalent human fungal pathogens that
cause both superficial and systemic diseases (candidiasis) in
patients with impaired immunity. In severe cases, the mortality
and morbidity range from 40-60% [4,5]. In fact, candidiasis is
the fourth leading type of hospital-acquired infections in clinical
settings [6,7]. Although C. albicans is the major causative
agent of candidiasis, recent epidemiological and clinical studies
have shown an escalating number of bloodstream infections
caused by non-albicans Candida species, which accounted for
36-63% of candidemia [8-11].
C. dubliniensis is now firmly recognized as an emerging and
medically-relevant opportunistic human fungal pathogen,
especially in the oral cavity of patients with AIDS and diabetes
mellitus. Epidemiological studies indicated a worldwide spread
of C. dubliniensis-related infections [12,13]. C. dubliniensis has
been isolated from other body sites including respiratory tract
and blood [14,15], with up to 7% of candidemia caused by this
pathogenic fungus [16]. In addition, azole-resistant C.
dubliniensis isolates have been frequently reported in
antifungal interventions, in particular to repeated and lengthy
treatments [17,18], suggesting a dire need for novel
approaches and strategies in treating this notorious human
fungal pathogen.
In the course of our continuing efforts to characterize small
molecules with novel antifungal activity, we have demonstrated
the potent in vitro antifungal activity of purpurin, a natural red
anthraquinone pigment in madder roots (Rubia tinctorum L.),
against a panel of six pathogenic Candida species [19]. In
particular, purpurin was found inhibitory to C. albicans biofilm
development by downregulation of the expression of hypha-
specific genes and the central morphogenetic regulator Ras1p
[20]. C. dubliniensis is a close relative to C. albicans as they
share >80% identity in genome sequence [21]. C. dubliniensis
and C. albicans are the only Candida species that can form
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true hyphae [22], and C. dubliniensis biofilms have been
documented in bloodstream infections and on the surfaces of
different biomaterials in the presence of saliva and serum
[23-25]. Candida biofilms are heterogeneous sessile
communities of yeast and hyphal cells in extracellular matrix,
and are highly resistant to antifungal chemotherapy [26,27]. It
has been estimated that 80% of microbial infections are biofilm-
associated [28]. Thus, suppression of biofilms could be an
effective measure to tackle with Candida virulence and
pathobiology. The present study was designed to investigate
the in vitro effect of purpurin on C. dubliniensis biofilms, with
special attention on its correlation to cell demise.
Results and Discussion
The main etiopathologic role of biofilms in pathogenic
Candida fungi is its ability to maintain a community of invasive
fungal population that serves as a reservoir for recurrent host
infection and disease dissemination [29]. Similar to its
phylogenetically closely related species C. albicans, C.
dubliniensis forms true hyphae and biofilms on both abiotic and
biotic surfaces [24]. The increasing clinical prevalence of C.
dubliniensis as an emerging human fungal pathogen is
reflected by an astonishing number of reports in detecting
bloodstream isolates and medical devices such as catheters
and implanted materials [17,18,30].
Our laboratory recently deciphered the mechanisms of action
of purpurin against Candida fungi through perturbation of
mitochondrial homeostasis and initiation of apoptosis [19].
More experiments indicated that purpurin also interferes with C.
albicans biofilm development at sub-MIC levels (3 µg/ml) [20].
In the present study, we explored the antifungal activity of
purpurin on C. dubliniensis biofilms and evaluated several
biochemical hallmarks of cell demise (apoptosis), an area that
is still relatively unexplored in this Candida species. The
antifungal activity of purpurin on C. dubliniensis biofilms was
evaluated semi-quantitatively by using 3-bis(2-methoxy-4-
nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT)
reduction assay. The inhibitory effect was concentration-
dependent, as revealed by a progressive reduction in cell
viability with increasing concentrations of purpurin (Figure 1A).
The metabolic activity of C. dubliniensis during biofilm
formation was reduced by ~45% at 1 µg/ml and by ~65% at 3
µg/ml. Pre-formed (mature) C. dubliniensis biofilms were less
susceptible to purpurin; the cell viability was reduced by ~17%
at 1 µg/ml and by ~40% at 3 µg/ml (Figure 1B). Scanning
electron microscopy (SEM) images showed that purpurin
inhibited biofilm development in C. dubliniensis, a scanty
architecture with reduced hyphal growth was evident in
purpurin-treated biofilms (Figure 2A-D). Considering the
differences in phenotypic properties of C. dubliniensis to its
sibling C. albicans, our data demonstrated that C. dubliniensis
is more vulnerable as lower concentration of purpurin (1 µg/ml)
was sufficient to abrogate biofilm development. As in other
biofilm-forming microbes, the structurally well-organized mature
C. dubliniensis biofilms were more resistant to purpurin,
presumably due to poor penetration.
The in vitro effect of purpurin on C. dubliniensis biofilms
prompted us to evaluate the presence of apoptotic features,
namely reactive oxygen species (ROS), mitochondrial
membrane potential (MMP), and DNA degradation, upon
exposure to purpurin. Apoptosis is a highly sophisticated
cellular process that leads to cell death in multicellular
organisms and is crucial for normal growth, development, and
cell maintenance. Candida fungi exhibit biochemical hallmarks
typical to mammalian apoptosis in response to diverse
environmental cues [31-36], in which mitochondria play a
pivotal role in controlling both caspase-dependent and
caspase-independent cell death pathways. Mitochondrial
dysfunction is regarded as the onset of apoptosis [37-40].
Moreover, it has been shown that activation of C. albicans
metacaspase is associated with elevation of intracellular ROS
levels [41].
Therefore, we sought to evaluate the effect of purpurin on
mitochondrial homeostasis. Purpurin increased the intracellular
ROS levels in C. dubliniensis biofilms in a concentration-
dependent manner, as revealed by a progressive elevation of
fluorescence intensity. At 1 µg/ml, the endogenous ROS levels
were increased by ~11%, and by ~27% at higher concentration
(10 µg/ml) (Figure 3). Immense elevation of intracellular ROS
levels is regarded as an onset of apoptosis, which is followed
by depolarization of MMP [42]. To this end, we used the
lipophilic fluorescent dye 5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethyl-imidacarbocyanine iodide (JC-1) to measure MMP in
purpurin-treated C. dubliniensis biofilms. Intact MMP allows the
cationic dye to enter the mitochondrial matrix and form J-
aggregates (red fluorescence) beyond critical concentration.
On the contrary, cells with depolarized MMP fluoresce green
due to monomeric JC-1 [19]. The ratio of red fluorescence
(FL-2) to green fluorescence (FL-1) represents the change of
MMP in cell population. As expected, purpurin elicited a
concentration-dependent depolarization of MMP in C.
dubliniensis biofilms. At 1 µg/ml, MMP was decreased by ~12%
and by 57 % at 10 µg/ml (Figure 4).
Collapse of MMP triggers a series of downstream cellular
events that lead to disorganization of DNA and therefore cell
death [43,44]. We assessed the effect of purpurin on DNA
integrity in C. dubliniensis biofilms by using the TUNEL assay.
DNA degradation results in a multitude of 3’-OH termini of DNA
ends that can be labelled by fluorescent-tagged deoxyuridine
triphosphate nucleotides using terminal deoxynucleotidyl
transferase-mediated dUTP nick end labelling (TUNEL) assay
[45]. Untreated fungal cells did not emit green fluorescence;
while TUNEL-positive cells (green fluorescence) were detected
upon purpurin treatment in C. dubliniensis biofilms (Figure 5A-
D).
Activation of caspase is a distinct biochemical marker of
apoptosis. Although no bona fide caspase is found in fungi, a
distant relative called metacaspase has been characterized in
Saccharomyces cerevisiae and C. albicans [41,46]. We
therefore examined the presence of activated metacaspases in
purpurin-treated C. dubliniensis biofilms by using FITC-VAD-
FMK. FITC-VAD-FMK is a cell permeable caspase inhibitor that
specifically binds to activated caspases [47]. However, no
green fluorescence could be observed in purpurin-treated C.
Caspase-Independent Apoptosis in C. Dubliniensis
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Figure 1.  Effect of purpurin on Candida dubliniensis biofilms.  A) Biofilm formation of C. dubliniensis MYA-646. B) Mature
biofilms. In both cases, biofilms were incubated with the indicated concentration of purpurin for 24 h at 37°C. The metabolic activity
of the biofilms was assessed semi-quantitatively using XTT reduction assay. The activity of samples without purpurin treatment (i.e.
DMSO only) (0 µg/ml) was taken as 100%. Results shown were the average of three independent experiments ± SD. *p<0.05 when
compared with the untreated controls.
doi: 10.1371/journal.pone.0086032.g001
Caspase-Independent Apoptosis in C. Dubliniensis
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dubliniensis biofilms (data not shown), suggesting an absence
of activated metacaspases. Nevertheless, a putative
metacaspase sequence (Cd36_85170) has been annotated in
C. dubliniensis genome (http://www.candidagenome.org/), and
we have detected the presence of activated metacaspase upon
exposure of planktonic cells of C. dubliniensis to apoptotic
levels of amphotericin B or acetic acid (P. W. K. Tsang,
unpublished data). Functional significance of this
uncharacterized open reading frame in apoptosis is in progress
in our laboratory.
C. dubliniensis poses a serious health threat to humans and
puts heavy economic burden on our society. Strategies that
work by switching on endogenous cell death mechanisms
specific to C. dubliniensis could be a novel and tangible
antifungal approach against this emerging human fungal
pathogen. Our findings clearly demonstrated that purpurin
triggers mitochondrial-mediated apoptotic pathway in C.
dubliniensis biofilms without the involvement of activated
metacaspases, suggesting that purpurin-mediated cell death in
C. dubliniensis does not require the proteolytic activity of
metacaspases. This is an entirely new antifungal action
mechanism which is different from the standard antifungal
agents in clinical settings: flucytosine inhibits DNA synthesis;
polyenes cause membrane damage; azoles affect sterol
metabolism; and echinocandins inhibit cell wall synthesis.
Nevertheless, the usefulness of these antifungal agents has
been hampered by severe side effects, poor therapeutic index,
and the emergence of multidrug resistance [48,49]. Therefore,
the unique antifungal action of purpurin on C. dubliniensis
could be of particular clinical relevance in the design of more
selective and effective therapeutic treatments. One aspect
could be killing of C. dubliniensis biofilms via induction of the
Figure 2.  Scanning electron microscopy images of Candida dubliniensis biofilms.  Representative SEM images showing the
topography of C. dubliniensis biofilms. Fungal biofilms were formed on plastic coverslips, processed, and coated with gold before
viewing (magnification 500×). A) Biofilm formation in the absence of purpurin. B) Biofilm formation in the presence of purpurin (1 µg/
ml). C) Pre-formed biofilms in the absence of purpurin. D) Pre-formed biofilms in the presence of purpurin (1 µg/ml).
doi: 10.1371/journal.pone.0086032.g002
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endogenous mitochondrial-mediated apoptotic pathway.
Another aspect could be a combined use of purpurin with the
conventional antifungal agents to reduce potential side effects
and the likelihood of acquired multidrug resistance.
In conclusion, the findings of the present study provide solid
evidence that purpurin triggered apoptosis-like features in C.
dubliniensis biofilms. As C. dubliniensis and C. albicans belong
to the CTG clade, it is not surprising that they share common
core pathways in metabolism. Nonetheless, a comparative
analysis of calcineurin signalling pathways between C.
dubliniensis and C. albicans indicated differential scenarios in
pH homeostasis [50]. Another study revealed a rewiring of iron
assimilation gene expression in C. dubliniensis [51]. Thus,
comparing metabolic pathways between these two species not
only helps gain further insights into their evolutionary
divergence, but also alludes to a functional characterization of
core machineries responsible for their pathogenicity. For
instance, a better understanding of the cell death mechanisms
can be beneficial to the design of innovative antifungal
strategies that target the core components specifically.
Materials and Methods
Strains, cultivation and chemicals
The reference laboratory strain C. dubliniensis MYA-646 was
used throughout the study, and was routinely cultured in YPD
agar (10 g/l yeast extract, 20 g/l peptone, 20 g/l dextrose, 20 g/l
agar) at 30°C. To prepare a standard cell suspension, a single
colony was inoculated into YNB medium (6.7 g/l yeast nitrogen
base w/o amino acids, 20 g/l dextrose) and incubated for 18 h
at 30°C with agitation (200 rpm). Fungal cells were harvested
by centrifugation, washed twice with phosphate-buffered saline
(PBS) (pH 7.2), and resuspended at 1 × 107 cells/ml. Purpurin
(purity >99%) was purchased from TimTec Inc. (Newark, DE,
USA). Stock solution of purpurin was prepared in distilled
dimethyl sulphoxide (DMSO) and kept at -20°C until use. The
final concentration of DMSO was 1% in all assays. Other
chemicals were obtained from commercial suppliers with the
highest grade available.
Effect of Purpurin on C. Dubliniensis Biofilm Formation
and Pre-Formed (Mature) Biofilms
Fungal biofilms were prepared as described [52] on
commercially available, pre-sterilized, flat-bottomed 96-well
Figure 3.  Effect of purpurin on intracellular ROS levels.  C. dubliniensis biofilms were treated with different concentrations of
purpurin (from 1 µg/ml to 10 µg/ml), and intracellular ROS levels were determined using DCFDA. Fluorescence intensity was
measured at 485 nm excitation and 535 nm emission. Results shown were the average of three independent experiments ± SD.
*p<0.05 when compared with the untreated controls.
doi: 10.1371/journal.pone.0086032.g003
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polystyrene microtitre plates (Iwaki). Standard cell suspension
of C. dubliniensis (100 µl) was transferred into the wells and
incubated for 1.5 h at 37°C with agitation (80 rpm). After the
adhesion phase, the liquid was aspirated and the wells were
washed twice with PBS to remove non-adherent cells. Fresh
YNB medium (200 µl) containing purpurin (1 µg/ml or 3 µg/ml)
was added to each well and the plates were incubated for an
additional 24 h at 37°C.
To investigate the effect of purpurin on pre-formed biofilms,
C. dubliniensis biofilms were prepared for 24 h at 37°C as
described above. The wells were washed twice with PBS and
fresh YNB medium (200 µl) containing purpurin (1 µg/ml or 3
µg/ml) was added and the plates were incubated for an
additional 24 h at 37°C. YNB medium with 1% DMSO was
included in control wells. The metabolic activity of the C.
dubliniensis biofilms, representing viability of the fungal cells,
was determined by using a standard XTT reduction assay that
measures mitochondrial dehydrogenase activity [52]. XTT
solution (1 g/l; 40 µl) was mixed with freshly prepared
menadione solution (0.4 mM; 2 μl) at 20:1 (v/v) immediately
prior to the assay. Thereafter, PBS (158 µl) was mixed with
XTT-menadione solution (42 µl) and transferred to each well
containing pre-washed biofilms, and incubated in the dark for 3
h at 37°C. Colour changes were measured at 492 nm with a
microtitre plate reader (SpectraMax 340 tunable microplate
reader; Molecular Devices).
Measurement of endogenous ROS levels
The effect of purpurin on intracellular ROS levels in C.
dubliniensis biofilms was examined by using the fluorescent
dye 2’,7’-dichlorofluorescein diacetate (DCFDA) (Molecular
Probes, CA, USA) [45]. Briefly, after treatment with different
concentrations of purpurin (from 1 µg/ml to 10 µg/ml), the
biofilms were washed twice with PBS, added with DCFDA (final
concentration: 20 µM) and incubated for 1 h at 37°C.
Fluorescence intensity was measured in a fluorescence plate
reader (TECAN Polarion, Tecan UK Ltd, Theale, UK) with a
485 nm excitation and 535 nm emission.
Measurement of MMP
The effect of purpurin on MMP of C. dubliniensis biofilms
was analyzed as described by using JC-1 [19]. Briefly, after
treatment with different concentrations of purpurin (from 1
µg/ml to 10 µg/ml), the biofilms were washed thrice with PBS,
followed by incubation with JC-1 (0.25 µM) (Molecular Probes,
CA) for 15 min at 35°C. Fluorescence intensities at FL-1
Figure 4.  Depolarization of MMP in purpurin-treated Candida dubliniensis biofilms.  Purpurin-treated C. dubliniensis biofilms
were incubated with JC-1. MMP was measured by flow cytometer at FL-1 (525 nm) and FL-2 (595 nm), and expressed as ratio of
FL-2/FL-1. Results shown were the average of three independent experiments ± SD. *p<0.05 when compared with the untreated
controls.
doi: 10.1371/journal.pone.0086032.g004
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(unhealthy cells emit green fluorescence, 525 nm) and FL-2
(healthy cells emit red fluorescence, 595 nm) were recorded by
a Beckman-Coulter flow cytometer, and the results were
expressed as a ratio of the mean values at FL-2 and FL-1.
Figure 5.  Effect of purpurin on DNA integrity (TUNEL assay).  Representative fluorescent images showing the occurrence of
DNA degradation in purpurin-treated C. dubliniensis biofilms captured by confocal microscope. A) Biofilms in the absence of
purpurin (Bright Field). B) Biofilms in the absence of purpurin (FITC). C) Biofilms in the presence of purpurin (1 μg/ml) (Bright Field).
D) Biofilms in the presence of purpurin (1 μg/ml) (FITC). Cells with damaged DNA emitted intense green fluorescence. The bar
represents 50 µm.
doi: 10.1371/journal.pone.0086032.g005
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Detection of activated metacaspases
The presence of activated metacaspases in C. dubliniensis
biofilms was evaluated by using CaspACE™ FITC-VAD-FMK
In Situ Marker (Promega, Madison, WI, USA). Briefly, purpurin-
treated C. dubliniensis biofilms were washed thrice with PBS
and incubated with CaspACE™ FITC-VAD-FMK In Situ Marker
(10 µM) for 20 min at 37°C in the dark. The cells were washed
twice and resuspended in PBS. Aliquots of fungal cells were
added to poly-L-lysine-coated glass slides and analyzed by
fluorescence microscopy using a confocal laser scanning
microscope (Fluoview FV 1000, Olympus, Tokyo, Japan).
Fungal cells containing activated metacaspases fluoresced
green.
TUNEL assay
DNA fragmentation in C. dubliniensis biofilms after treating
with purpurin was detected by using the In Situ Cell Death
Detection Kit (fluorescein) (Roche, Penzbery, Germany) [31].
Briefly, after incubation with purpurin, the biofilms were washed
thrice with PBS and fixed with 2% paraformaldehyde for 1 h at
20°C. The biofilms were rinsed thrice with PBS, and then
incubated with permeabilization solution (0.1% Triton X-100,
0.1% sodium citrate) on ice for 2 min. The biofilms were rinsed
twice with PBS and labelled with 50 µl TUNEL reaction mixture
for 1 h at 37°C in a humidified incubator in the dark. The cells
were mounted under glass coverslip and analyzed by
fluorescence microscopy using a confocal laser scanning
microscope.
SEM analysis
C. dubliniensis biofilms were prepared on custom-made,
tissue culture-treated, polystyrene coverslips as described
[20,52]. Thereafter, the coverslips were washed twice with PBS
and placed in 1% osmium tetroxide for 1 h. Samples were
subsequently washed with distilled water, dehydrated in a
series of ethanol solutions (70% for 10 min, 95% for 10 min
and 100% for 20 min), and air-dried overnight in a desiccator
prior to sputter coating with gold (JFC1 100; JEOL). The
surface topographies of the C. dubliniensis biofilms were
viewed with a scanning electron microscope (Philip XL30CP).
Statistical analysis
All experiments were performed in triplicate in three different
occasions and all data were expressed as the mean values
with the corresponding standard deviation (SD). Statistical
significance between treated and control groups was assessed
by Mann-Whitney U test. A p-value of <0.05 was considered
statistically significant.
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